Approaches to antiviral chemotherapy.
D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000627:therapeutic use; D046508:Culture Techniques; D003561:Cytarabine / Q000627:therapeutic use; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D004261:DNA Replication / Q000187:drug effects; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology / Q000627:therapeutic use; D007223:Infant; D007251:Influenza, Human / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use; D051379:Mice; D010617:Phenanthridines / Q000627:therapeutic use; D011051:Poliomyelitis / Q000188:drug therapy; D011485:Protein Binding; D012367:RNA, Viral / Q000096:biosynthesis; D011817:Rabbits; D012293:Rifampin / Q000627:therapeutic use; D012899:Smallpox / Q000188:drug therapy; D013698:Templates, Genetic / Q000187:drug effects; D013882:Thiosemicarbazones / Q000009:adverse effects / Q000627:therapeutic use; D014764:Viral Proteins / Q000096:biosynthesis; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D001562:Benzimidazoles; D010617:Phenanthridines; D012367:RNA, Viral; D013882:Thiosemicarbazones; D014764:Viral Proteins; D003561:Cytarabine; D007372:Interferons; D000547:Amantadine; D004254:DNA Nucleotidyltransferases; D007065:Idoxuridine; D012293:Rifampin